EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›IRIX

IRIX

IRIDEX CORP

Next earnings Aug 10, 2026 · consensus $-0.01 EPS, $13.9M rev

Last earnings +3.4% on 2026-05-19

Avoid
$1.13
▼ -4.24%
$1.13▲ +18.70%
over 1Y
L $0.88EODHDH $1.56
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-4.2%
1W-4.2%
1M+9.7%
3M+14.1%
YTD-3.4%
1Y+18.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
C
Valuation
Fair value
Filings
Clean
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy

Revenue grew 8.2% YoY; but unprofitable (net margin -8.4%).

Revenue (FY2026) $52.7M · FY2026

IRIDEX CORP shows $52.7M in FY2026 revenue (+8.2% YoY), a -8.4% net margin, and -90.1% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY26
Revenue$36.3M$57.0M$51.9M$48.7M$52.7M
Gross profit$15.6M$25.4M$21.8M$19.5M$19.2M
Operating income-$6.58M-$7.54M-$10.0M-$8.30M-$2.57M
Net income-$6.33M-$7.55M-$9.57M-$8.91M-$4.44M
Diluted EPS-$0.46-$0.47-$0.59-$0.54-$0.26
Net margin-17.4%-13.2%-18.5%-18.3%-8.4%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$16.2M
EV / EBITDA—
EV / Sales0.3
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-22.7%
FCF yield-11.5%

Quality & risk

ROIC (est.)-26.6%
Free cash flow-$2.26M
Total debt$2.70M
Net cash$3.33M
Altman Z-Score-1.94 distress
Piotroski F-Score5/9

Capital returns

Buyback yield8.0%
Dividend yield (est.)—
Shareholder yield8.0%
Shares Δ YoY+3.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 8-K Other event2026-06-18
  2. 8-K Earnings results2026-05-19
  3. 10-Q Quarterly report2026-05-19
  4. DEF 14A Proxy statement2026-04-24
  5. 10-K Annual report2026-04-02
  6. 8-K Earnings results2026-03-26
  7. 8-K Material agreement2026-03-13
  8. 8-K Earnings results2026-01-12
  9. 8-K Reg FD disclosure2025-12-11

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-122026-06-18open ↗4Period ending 2026-06-132026-06-16open ↗4Period ending 2026-06-132026-06-16open ↗4Period ending 2026-06-122026-06-15open ↗4Period ending 2026-06-112026-06-12open ↗4Period ending 2026-06-082026-06-09open ↗4Period ending 2026-06-052026-06-08open ↗4Period ending 2026-06-032026-06-03open ↗SDFiling2026-06-01open ↗4Period ending 2026-05-262026-05-26open ↗4Period ending 2026-05-262026-05-26open ↗10-QPeriod ending 2026-04-042026-05-19open ↗

Quality score

C
ValueGrowthProfitHealthMom.
ValueA+
GrowthA-
ProfitabilityF
Financial healthD
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
Revenue
$52.7M
+8.2% YoY
Net margin
-8.4%
ROE
-90.1%
P/E
—

SEC fundamentals · FY 2026

'21'22'23'24'26

■ revenue · ■ net income, by fiscal year

Revenue$52.7M+8.2%
Net income-$4.44M+50.2%
Gross profit$19.2M-1.4%
Operating income-$2.57M+69.0%
Diluted EPS-$0.26+51.9%
Cash & equivalents$6.03M+152.5%
Total assets$29.2M+0.1%
Total liabilities$24.2M-10.4%
Stockholders' equity$4.92M+134.7%
Gross: 36.5%Op.: -4.9%L/E: 4.92x

Frequently asked

Is IRIDEX CORP (IRIX) a buy?
IRIX currently carries a Avoid rating with 3/5 conviction, derived from its latest SEC filings. Revenue grew 8.2% YoY; but unprofitable (net margin -8.4%).
What is IRIDEX CORP's quality score?
IRIX scores 57.62745098039216/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001006045, latest 10-Q filed 2026-05-19) · EODHD · as of 6/25/2026, 11:29:26 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 5 open-market buys · 0 sales

2026-06-13
Dizon Romeo R
Chief Financial Officer
Tax2.69K @ $1.12$3.01K
2026-06-13
Mercer Patrick
President and CEO
Tax3.99K @ $1.12$4.47K
2026-06-12
Dizon Romeo R
Chief Financial Officer
Buy975.00 @ $1.14$1.11K
2026-06-11
Dizon Romeo R
Chief Financial Officer
Buy1.68K @ $1.14$1.91K
2026-06-08
Dizon Romeo R
Chief Financial Officer
Buy2.40K @ $1.12$2.69K
2026-06-05
Dizon Romeo R
Chief Financial Officer
Buy2.52K @ $1.15$2.90K
2026-06-03
Dizon Romeo R
Chief Financial Officer
Buy2.40K @ $1.17$2.81K
2026-05-26
Mercer Patrick
President and CEO
Tax19.2K @ $1.01$19.4K

Earnings history

beat/miss · move
2026-05-19Beat +58.0% est▲ +3.45%8-K ↗
2026-03-26Beat +51.0% est▲ +1.89%8-K ↗
2026-01-12Beat +51.0% est▲ +28.70%8-K ↗
2025-11-12Miss -47.1% est▼ -19.82%8-K ↗
2025-08-12Beat +34.6% est▲ +3.17%8-K ↗
2025-05-13—▼ -4.35%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product GrowthBullish
finance.yahoo.com· 2026-05-25
IRIDEX Corporation Q1 2026 Earnings Call SummaryBullish
finance.yahoo.com· 2026-05-20
Iridex reaffirms $51M-$53M 2026 revenue outlook while targeting $600,000 annualized cost reductionBullish
seekingalpha.com· 2026-05-19
The Zacks Analyst Blog Microsoft, AbbVie, BHP, CBL & Associates Properties and IRIDEXBullish
nasdaq.com· 2026-04-20
Top Analyst Reports for Microsoft, AbbVie & BHPBullish
finance.yahoo.com· 2026-04-17
Iridex's Q4 Loss Narrows Year Over Year on Retina Sales GrowthBullish
finance.yahoo.com· 2026-04-01

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score58 vs 67
Revenue growth8.2% vs 7.1%
Net margin-8.4% vs 10.5%
Return on equity-90.1% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 3d
Bullish
+0.15
vs typical · 3 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.